[1] Siegel R,Naishadham D,Jemal A. Cancer statistics,2013[J].CA Cancer J Clin,2013,63(1):11-30.[2] Marchevsky AM,Netson V,Martin SE,et al.Telecytology of fine-needle aspiration biopsies of the pancreas:a study of well-differentiated adenocarcinoma and chronic pancreatits with atypical repair changes[J].Diagen Cytopathol,2003,28(3):147-152.[3] 吕楠,张宏艳,刘端祺.胰腺癌流行病学研究进展[J].中国肿瘤临床,2007,34(23):1368-1372.[4] 王爱林,袁宝山,艾青,等.43例胰腺癌患者血清CA19-9、CA125、CEA水平检测及分析[J].山东医药,2010,50(35):39-40.[5] 王佩.血清CA19-9、CA125及CEA检测在胰腺癌化疗病人诊断及预后中的临床意义分析[J].现代预防医学,2011,38(23):5036-5037,5039.[6] Goonetilleke KS,Siriwardena AK.Systematic review of carbohydrate antigen(CA 19-9)as a biochemical marker in the diagnosis of pancreatic cancer[J].Eur J Surg Oncol,2007,33:266-270.[7] Chen Y,Gao SG,Chen JM,et al.Serum CA242,CA199,CA125,CEA,and TSGF are biomarkers for the efficacy and prognosis of cryoablation in pancreatic cancer patients[J].Cell Biochem Biophys,2015,71:1287-1291.[8] Huang Z,Liu F.Diagnostic value of serum carbohydrate antigen 19-9 in pancreatic cancer:A meta-analysis[J].Tumour Biol,2014,35(8):7459-7465.[9] Wang Z,Tian YP.Clinical value of serum tumor markers CA19-9,CA125 and CA72-4 in the diagnosis of pancreatic carcinoma[J].Mol Clin Oncol,2014,2(2):265-268.[10] 郭波,郑萍,杨菲,等.抗原致敏期缺损补体增强抗肿瘤免疫效应[J].免疫学杂志,2008,24(2):127-129.[11] 陈炯,郑春生,汤厚阔,等.载脂蛋白E和补体C4b1在人胰腺癌组织中的表达及意义[J].中华胰腺病杂志,2011,11(2):89-91.[12] 陈炯,武文,汤厚阔,等.胰腺癌患者血清的比较蛋白质组学研究及其意义[J].中华外科杂志,2013,51(1):62-65.[13] Chen J,Wu W,Zhen C,et al.Expression and clinical significance of complement C3,complement C4b1 and apolipoprotein E in pancreatic cancer[J].Oncol Lett,2013,6(1):43-48.[14] 谭树芬,杨宏英,李树清,等.癌症患者血脂水平变化[J].微循环学杂志,2013,23(3):1-2,6.[15] 吴正青,杨永青.不同类型肿瘤患者的血脂和肿瘤标志物水平的临床分析[J].放射免疫学杂志,2012,25(2):195-197.[16] 雒守凤.探讨不同类型肿瘤患者的血脂和肿瘤标志物水平的临床研究[J].中国保健营养(下旬刊),2012,22(10):3704.[17] Fiorenza AM,Branchi A,Sommariva D.Serum lipoprotein profile in patients with cancer.A comparison with non-cancer subjects[J].Int J Clin Lab Res,2000,30(3):141-145.[18] 高艳红,张妍,田亚平,等.不同类型肿瘤患者的血脂水平分析[J].标记免疫分析与临床,2010,17(5):277-280.[19] 范大光,梁焕芳,马剑方,等.血清脂蛋白与胃癌淋巴结转移及肿瘤分期的关系[J].肿瘤研究与临床,2011,23(7):447-449.[20] 曹军丽,王欣,董立新,等.胃肠道恶性肿瘤患者血浆D二聚体和脂蛋白浓度变化及临床意义[J].中国综合临床,2014,30(5):517-521.[21] 李传凤,李军,白鹏,等.结直肠肿瘤与患者血脂代谢水平[J].北京大学学报:医学版,2011,43(3):432-435. |